Diosmetin protects against LPS-induced acute lung injury (ALI) via increasing the expression of Nrf2 along with its target gene HO-1 and blocked the activation of NLRP3 inflammasome both in vivo and in vitro [28]. The gene discussed is HMOX1; the disease is acute lung injury.